Friday, August 12, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Mediknowledge

Treatment and Prognosis of Mediastinitis

by Medical Finance
in Mediknowledge
Mediastinal Mass
10
SHARES
106
VIEWS
Share on FacebookShare on Twitter

Mediastinal infections (jointly referred to as mediastinitis) are primarily related to surgery, perforation of the esophagus and infectious spread from adjacent regions, with incidence varying by clinical setting. Postoperative mediastinitis is the most frequently observed entity.

Mediastinal Mass

Image Credit: P.VARISA/Shutterstock.com

When confronted with acute mediastinitis, all treatment endeavors should be tailored to the primary pathology and associated clinical manifestations. While surgery is often pursued in acute cases of the disease, in chronic cases the utility of surgical treatment is merely palliative.

In general, a multidisciplinary specialist approach is warranted, considering both the overall patients’ condition and the specific disease dynamics and characteristics that resulted in mediastinitis in the first place. Early diagnosis, definitive initial therapy and scheduled computed tomography follow-up after initial treatment are needed to assess the need for surgical re-intervention.

General principles of mediastinitis management

Even though the management of mediastinitis is guided by the underlying disease etiology, certain elements of care are common to all patients. As a rather severe infection, mediastinitis often advances into septic shock.

In patients with descending necrotizing mediastinitis, there is a strong correlation between the time of admission to the intensive care units (and pertaining severity scores) and overall mortality.

A compromised airway should be expected early in the course of management, especially in cases that are known to involve the neck and upper part of the mediastinum. Due to local swelling and lockjaw, frontal access to the airway and laryngoscopic visualization may be compromised.

Expert guidelines stipulate that the anesthesiologist should manage the airway (with a well-delineated alternative plan).

However, the involvement of both maxillo-facial surgeon and otolaryngologist during the intubation planning process is endorsed, but also their presence at the time of intubation to mitigate the potential difficulties.

Antimicrobial treatment

When antimicrobial treatment of mediastinitis is considered, it should be guided under the same principles akin to empirical antimicrobial therapy in patients admitted to the intensive care unit.

However, microbiological samples have to be collected before antibiotics are started. As specific data on the efficacy of antibiotics in mediastinitis are scarce, current recommendations are still mostly based on expert opinion.

In mediastinitis caused by deep sternal wound infection, empirical antimicrobial treatment has to cover methicillin-susceptible Staphylococcus aureus, Gram-negative bacteria of gastrointestinal origin and skin commensal bacteria. Broad-spectrum beta-lactam penicillin is usually prescribed.

Patients presenting with mediastinitis due to esophageal perforation usually receive broad-spectrum antimicrobial agents intravenously that cover aerobic and anaerobic bacterial species that reside in the upper gastrointestinal tract. Drugs of choice include third-generation cephalosporins (usually with the addition of metronidazole).

Finally, in mediastinitis that arises due to descending necrotizing mediastinitis, empirical treatment has to cover aerobic and anaerobic bacteria associated with infections of the ear, nose, and throat. A similar scheme to the aforementioned approach in esophageal perforation is recommended, usually with the addition of clindamycin.

Surgical approaches

Controlling the infectious source and tissue debridement (when necessary) are two fundamental steps in the surgical treatment of mediastinitis. The strategy is decided according to the underlying cause and magnitude of the disease. This is usually established with the use of imaging techniques, more specifically cross-sectional imaging studies.

When mediastinitis is situated in the upper part of the mediastinum, it is usually sufficient to conduct transcervical drainage; on the other hand, cases of the disease extending below the tracheal carina (ridge separating the openings of two main bronchi) usually necessitate cervical/transthoracic drainage.

It has to be emphasized that a delay between diagnosing the condition and surgical intervention is linked to poorer outcomes and, therefore, this period should not be longer than 24 hours.

Prevention of mediastinitis

A myriad of preventative measures is effective for reducing the incidence of mediastinitis. Most of them are in line with basic measures that are used to prevent surgical site infections – most notably preoperative screening to exclude the carriage of multidrug-resistant microorganisms.

Naturally, strict adherence to aseptic techniques during surgery, antimicrobial prophylaxis, appropriate hemostasis, precise surgical technique, careful sternal closure, and adequate wound management are all pivotal for preventing the rise of mediastinitis, with all its potential dire consequences.

Sources

  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1312210/
  • https://academic.oup.com/ejcts/article/51/1/10/2670570
  • https://onlinelibrary.wiley.com/doi/abs/10.1002/hed.24183
  • https://link.springer.com/article/10.1007%2Fs00104-016-0172-7
  • https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(19)30394-5/fulltext
  • Rees CJ, Cantor RM, Pollack Jr. CV, Riese VG. Mediastinitis. In: Pollack Jr. CV (eds) Differential Diagnosis of Cardiopulmonary Disease. Springer, Cham, Springer Nature Switzerland AG 2019

Further Reading

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Image Credit: MAD.vertise/Shutterstock.com

Pediatric Robotic Surgery: past, present and potential

by Medical Finance
August 7, 2022
0

Written by Keynote Contributor, Dr. Joseph G. Barone. The orderly is shocked because a child is undergoing surgery, but no...

prioritizing efficacy when considering quality of life

prioritizing efficacy when considering quality of life

by Medical Finance
August 6, 2022
0

Written by Keynote Contributor, Dr. Cristina Suárez. It is an exciting yet challenging time to be a treating physician in...

Genetic disease

Computational biology in rare disease research

by Medical Finance
August 6, 2022
0

Written by Keynote Contributor, Professor Damian Smedley. Rare diseases affect 6-8% of the world’s population and, although we know that...

Image Credit: Kateryna Mostova/Shutterstock.com

how obstructive sleep apnea and COPD coexist

by Medical Finance
August 5, 2022
0

Written by Keynote Contributor, Dr. Praveen Bhatia, MBBS, FRCP An introduction to COLDOSA In the medical sphere, we love acronyms. You might...

Depression and Insomnia

clinical treatments for a common comorbidity

by Medical Finance
August 4, 2022
0

Given these strong sleep-mood relationships, it is not surprising that insomnia and depression frequently co-occur. For example, up to 90%...

The Surge of Sensationalist COVID-19 AI Research

The Surge of Sensationalist COVID-19 AI Research

by Medical Finance
August 4, 2022
0

There seems to be a tendency to hastily use imperfect and questionable data to train an AI solution for COVID-19,...

Next Post
Study: Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants. Image Credit: BaLL LunLa/Shutterstock

Vaccine breakthrough COVID-19 infections found to be less likely transmitted

Using IVIM Technology Inc.’s IntraVital Microscopy system for in vivo drug delivery monitoring and in vivo drug efficacy monitoring

Using IVIM Technology Inc.’s IntraVital Microscopy system for in vivo drug delivery monitoring and in vivo drug efficacy monitoring

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Two cell embryo Mitosis under microscope 3D illustration Illustration Andrii Vodolazhskyi M1 4bb73c51d46c449285a21e8af28684d6 620x480
    UW Medicine scientists contribute to the publication of first complete, gapless genome sequence
  • Protein 620x480
    Orally-active senolytics can boost a key beneficial protein in mice and humans
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply